For weeks, the entry posse around the unvaccinated tennis superstar kept the sports world in suspense. Novak Djokovic is now investing in research – to combat Covid-19.
Serbian tennis star Novak Djokovic, who is not vaccinated against Covid-19, has acquired the Danish biotech company QuantBioRes. He bought around 80 percent of the shares, company boss Ivan Loncarevic told the Reuters news agency. QuantBioRes wants to develop a medical treatment against Covid-19. Around eleven people are currently working on it in Denmark, Australia and Serbia. Loncarevic did not want to say how much Djokovic invested.
It’s a curious new development about the world number one: Djokovic recently made headlines because he was denied entry to Australia (read more on the subject here). The 34-year-old defending champion wanted to take part in the Australian Open, the first Grand Slam tournament of the year, with an exemption from the vaccination requirements.
